Breast Diseases  >>  Stimuvax (tecemotide)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stimuvax (tecemotide) / EMD Serono, Ono Pharma
STRIDE, NCT00925548 / 2008-005544-17: - STimulating Immune Response In aDvanced brEast Cancer

Terminated
3
16
US, Europe, RoW
Tecemotide (L-BLP25) and Hormonal Treatment, Placebo of tecemotide (L-BLP25) and Hormonal Treatment, cyclophosphamide, sodium chloride (NaCl)
EMD Serono
Breast Cancer
08/10
08/10

Download Options